Literature DB >> 29155694

PARACENTRAL ACUTE MIDDLE MACULOPATHY IN PRIMARY CONGENITAL GLAUCOMA.

Yavuz K Aribas1, Zeynep Aktas, Kemal Bayrakceken, Tuba Atalay, Sengul Ozdek.   

Abstract

PURPOSE: To report a case of primary congenital glaucoma associated with paracentral acute middle maculopathy.
METHODS: A case report.
RESULTS: A 14-year-old girl with undiagnosed primary congenital glaucoma was referred for the evaluation of sudden vision loss a week after the initial symptoms. Visual acuity was counting fingers at 2 m in the right eye. Examination of her right eye revealed corneal stromal scar like Haab striae, splinter hemorrhage at the temporal border of the optic disk, perivenular hemorrhage, and fern-like white area at the macula. On optical coherence tomography of the right eye, hyperreflective plaques at the level of the inner nuclear layer/outer plexiform layer were present, corresponding to the opaque areas in fundoscopy. On optical coherence tomography angiography of the right eye, ischemic areas in deep capillary plexuses were present. These findings in optical coherence tomography angiography and optical coherence tomography were consistent with paracentral acute middle maculopathy.
CONCLUSION: This is the first case of primary congenital glaucoma associated with paracentral acute middle maculopathy in the literature, and primary congenital glaucoma might be a predisposing factor.

Entities:  

Mesh:

Year:  2020        PMID: 29155694     DOI: 10.1097/ICB.0000000000000652

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  2 in total

1.  Paracentral acute middle maculopathy secondary to high intraocular pressure: a case report.

Authors:  Jia Li; Yan-Xia Li; Jing Zhao; Ya-Juan Zheng
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

2.  Peripapillary and macular retinoschisis - A vision-threatening sequelae of advanced glaucomatous cupping.

Authors:  Vijayalakshmi A Senthilkumar; Chitaranjan Mishra; Naresh B Kannan; Priyanka Raj
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.